| Income statements | |||||
|---|---|---|---|---|---|
| Euro 000 | 2008 | 2009 | 2010 | 2011 | 2012 |
| Net sales | 1,319,666 | 1,316,595 | 1,513,596 | 1,493,767 | 1,489,285 |
| Cost of sales | (410,632) | (441,813) | (511,117) | (478,981) | (436,271) |
| Gross profit | 909,034 | 874,782 | 1,002,479 | 1,014,786 | 1,053,014 |
| Other income | 45,565 | 52,744 | 58,090 | 56,739 | 55,904 |
| Selling and marketing expenses | (538,115) | (559,456) | (643,544) | (649,059) | (644,147) |
| Administrative expenses | (229,144) | (221,288) | (259,674) | (264,312) | (289,652) |
| Operating profit | 187,340* | 146,782* | 157,351 | 158,154 | 175,119 |
| Exceptional items ** | (8,700) | (1,314) | (10,772) | (5,908) | 0 |
| Operating profit | 178,640 | 145,441 | 168,123* | 164,062* | 175,119 |
| Exceptional items ** | |||||
| Financial income | 8,717 | 3,059 | 17,924 | 33,594 | 21,557 |
| Financial expenses | (45,821) | (31,247) | (40,058) | (69,934) | (43,782) |
| Financial expenses, net | (37,104) | (28,188) | (22,134) | (36,340) | (22,225) |
| Profit before tax | 141,536 | 117,253 | 135,217 | 121,814 | 152,894 |
| Current tax | (17,709) | (20,126) | (33,201) | (26,761) | (24,904) |
| Deferred tax | 561 | 3,185 | 15,521 | 4,767 | (7,384) |
| Net profit | 124,388 | 100,312 | 117,537 | 99,820 | (31,442) |
| 2008 | 2009 | 2010 | 2011 | 2012 | |
| Earnings per share before full dilution, Euro | 2.22 | 1.77 | 2.07 | 1.86 | 2.13 |
| Earnings per share after full dilution, Euro | 2.20 | 1.76 | 2.06 | 1.86 | 2.13 |
| *) Adjusted for exceptional items. | |||||
| **) 2003: Gain on disposal of subsidiary. 2004: Stock exchange listing expenses. 2005: Loss on disposal of subsidiary. 2007-2009: Restructuring costs. 2010: Restructuring costs and impairment Iran. 2011: Restructuring costs. | |||||